WuXi PharmaTech (Cayman) Company Profile (NYSE:WX)

About WuXi PharmaTech (Cayman) (NYSE:WX)

WuXi PharmaTech (Cayman) logoWuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Symbol: NYSE:WX
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $45.00
  • 200 Day Moving Avg: $43.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 25.93
  • P/E Growth: 0
 

Frequently Asked Questions for WuXi PharmaTech (Cayman) (NYSE:WX)

What is WuXi PharmaTech (Cayman)'s stock symbol?

WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."

How were WuXi PharmaTech (Cayman)'s earnings last quarter?

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) announced its quarterly earnings data on Tuesday, November, 3rd. The company reported $0.31 EPS for the quarter, meeting the Zacks' consensus estimate of $0.31. The firm earned $213.60 million during the quarter, compared to the consensus estimate of $205.24 million. The firm's quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.54 earnings per share. View WuXi PharmaTech (Cayman)'s Earnings History.

Who are some of WuXi PharmaTech (Cayman)'s key competitors?

How do I buy WuXi PharmaTech (Cayman) stock?

Shares of WuXi PharmaTech (Cayman) can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of WuXi PharmaTech (Cayman) stock cost?

One share of WuXi PharmaTech (Cayman) stock can currently be purchased for approximately $45.90.

Analyst Ratings

Consensus Ratings for WuXi PharmaTech (Cayman) (NYSE:WX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for WuXi PharmaTech (Cayman) (NYSE:WX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/5/2015Morgan StanleyDowngradeOverweight -> Equal WeightN/AView Rating Details
8/14/2015William BlairReiterated RatingOutperform -> BuyN/AView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for WuXi PharmaTech (Cayman) (NYSE:WX)
Earnings by Quarter for WuXi PharmaTech (Cayman) (NYSE:WX)
Earnings History by Quarter for WuXi PharmaTech (Cayman) (NYSE:WX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2015Q3$0.31$0.31$205.24 million$213.60 millionViewN/AView Earnings Details
8/13/2015Q215$0.39$0.38$195.26 million$194.14 millionViewListenView Earnings Details
5/13/2015Q1$0.32$0.36$174.29 million$180.00 millionViewListenView Earnings Details
3/5/2015Q414$0.53$0.55$189.54 million$190.60 millionViewListenView Earnings Details
11/12/2014Q314$0.48$0.54$172.60 million$173.60 millionViewListenView Earnings Details
8/13/2014Q214$0.47$0.49$162.11 million$163.40 millionViewListenView Earnings Details
5/14/2014Q114$0.39$0.30$145.00 million$146.70 millionViewListenView Earnings Details
3/5/2014Q413$0.43$0.53$155.76 million$157.10 millionViewN/AView Earnings Details
11/13/2013Q313$0.39$0.47$145.29 million$146.70 millionViewListenView Earnings Details
8/12/2013Q2 2013$0.39$0.46$141.10 million$142.33 millionViewN/AView Earnings Details
5/13/2013Q1 2013$0.32$0.35$130.02 million$131.90 millionViewListenView Earnings Details
3/7/2013Q4 2012$0.30$0.38$123.71 million$125.70 millionViewListenView Earnings Details
11/12/2012Q312$0.30$0.36$123.17 million$125.84 millionViewN/AView Earnings Details
8/13/2012$0.30$0.33ViewN/AView Earnings Details
5/10/2012$0.26$0.33ViewN/AView Earnings Details
3/8/2012$0.26$0.31ViewN/AView Earnings Details
11/10/2011$0.27$0.31ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for WuXi PharmaTech (Cayman) (NYSE:WX)
Current Year EPS Consensus Estimate: $1.51 EPS
Next Year EPS Consensus Estimate: $1.77 EPS

Dividends

Dividend History for WuXi PharmaTech (Cayman) (NYSE:WX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for WuXi PharmaTech (Cayman) (NYSE:WX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for WuXi PharmaTech (Cayman) (NYSE:WX)
Latest Headlines for WuXi PharmaTech (Cayman) (NYSE:WX)
Source:
DateHeadline
seekingalpha.com logoSky People Fruit Juice (An Update)
seekingalpha.com - January 9 at 3:22 PM
finance.yahoo.com logoWuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors
finance.yahoo.com - September 22 at 7:46 PM
streetinsider.com logoForm N-PX Managed Portfolio Series For: Jun 30
www.streetinsider.com - August 22 at 8:17 PM
bloomberg.com logoChina's Banks Help Finance $157 Billion M&A Spree
www.bloomberg.com - August 9 at 8:40 PM
marketwatch.com logoViral Clearance Market Worth 510.3 Million USD by 2020
www.marketwatch.com - April 4 at 10:45 AM
finance.yahoo.com logoWuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China
finance.yahoo.com - December 16 at 2:40 AM
finance.yahoo.com logoWuXi PharmaTech Presents 2015 Life Science and Chemistry Awards
finance.yahoo.com - December 13 at 6:00 PM
finance.yahoo.com logoWUXI PHARMATECH (CAYMAN) INC. Financials
finance.yahoo.com - December 8 at 1:09 PM
finance.yahoo.com logoDr. Ge Li Receives Executive of the Year Award from SCRIP
finance.yahoo.com - December 7 at 8:00 AM
finance.yahoo.com logoWuXi PharmaTech Announces Shareholders' Approval of Merger Agreement
finance.yahoo.com - November 24 at 10:00 PM
finance.yahoo.com logoThe State Of Chinese Company Take-Private Offers: A Look At WuXi PharmaTech
finance.yahoo.com - November 19 at 7:24 AM
finance.yahoo.com logoISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private Transaction
finance.yahoo.com - November 11 at 12:01 PM
finance.yahoo.com logoWuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China
finance.yahoo.com - November 10 at 4:30 PM

Social

Chart

WuXi PharmaTech (Cayman) (WX) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff